2.96
2.96 (-6.71%)
As of Mar 06, 2024
Bioxcel Therapeutics, Inc. [BTAI]
Source:
Company Overview
We are a clinical stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. Our drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. We believe that this differentiated approach has the potential to reduce the cost and time of drug development in diseases with a substantial unmet medical need.
Country | United States |
Headquarters | new haven, connecticut |
Phone Number | 203-643-8060 |
Industry | manufacturing |
CEO | Vimal Mehta |
Website | www.bioxceltherapeutics.com |